Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / ORD SHS
-
Total 13F shares
-
6,991,387
-
Share change
-
+4,853,220
-
Total reported value
-
$144,509,520
-
Put/Call ratio
-
73%
-
Price per share
-
$20.67
-
Number of holders
-
38
-
Value change
-
+$104,648,380
-
Number of buys
-
36
-
Number of sells
-
8
Institutional Holders of NEURODERM LTD - ORD SHS as of Q3 2015
As of 30 Sep 2015,
NEURODERM LTD - ORD SHS was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,991,387 shares.
The largest 10 holders included
Redmile Group, LLC, SCOPIA CAPITAL MANAGEMENT LP, venBio Select Advisor LLC, Longwood Capital Partners LLC, RA CAPITAL MANAGEMENT, LLC, CADIAN CAPITAL MANAGEMENT, LP, BAKER BROS. ADVISORS LP, PERCEPTIVE ADVISORS LLC, Arrowpoint Asset Management, LLC, and MENORA MIVTACHIM HOLDINGS LTD..
This page lists
38
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.